Gross Margin

The successful launch of rosacea treatment Emrosi™ generated $14.7M, driving Journey Medical's revenue to $61.9M and signaling a major strategic win.

Adhesives giant H.B. Fuller expands margins and raises its 2026 outlook, signaling operational strength amid market softness and supply chain turmoil.

The smart glasses maker reports record sales driven by niche products, yet continued investment in global expansion keeps the company in the red for now.

The MEMS specialist saw revenue dip on a sharp medical decline, but booming aerospace sales, a higher margin, and a new dividend signal a strategic pivot.

With adjusted EPS up 20.8%, HighCo's strategic acquisitions and focus on promotion activation signal a new era of specialized growth and market leadership.

Facing a historic downturn and geopolitical turmoil, the chemical industry gathers in Texas to debate its strategy for survival and transformation.

As safety tech fills our roads, Autel's newly ASE and I-CAR accredited ADAS program aims to fix a critical skills gap and ensure vehicle safety.

Two years in, Jennifer Sey's XX-XY Athletics has turned polarizing advocacy into millions in revenue, shaking up the sports apparel industry.

Global Battery Materials ships its first graphite samples and opens a Quebec lab, a major step toward a secure, ex-China battery supply chain for North America.

Riding high on record 2025 results and a new FDA approval, LivaNova faces intense scrutiny ahead of its May 6 earnings call. Can it sustain the momentum?

A new partnership aims to bring industrial-scale, clean-label cannabis extraction to the Garden State, promising a new standard for purity and consistency.

The firm leveraged its integrated insurance and investment model to achieve record revenue and a top-10 ranking while defying a looming advisor shortage.

As AI agents drive up costs and create a 'token shortage,' a new player unveils a distributed compute network to challenge the centralized cloud model.

Erdene begins gold production at its new Bayan Khundii mine, generating $31M in revenue while advancing major copper and molybdenum projects in Mongolia.

Amid a full-year revenue drop, the EdTech firm unveils a new AI product, banking on innovation and a new business model to chart a path to profitability.

Rithm Capital declared its 52nd straight dividend. Is its high yield and analyst praise enough to overcome recent stock woes and market skepticism?

Investors await East Side Games Group's year-end results to see if a costly Q3 investment in new titles will finally pay off and reverse recent losses.

As oncologists warn of supplement risks, one company founded by a doctor and caregiver aims to provide a safer, transparent path for cancer survivors.

A breakthrough in mycelium-based infection detection has prompted Mushrooms Inc. to halt a merger, betting its future on its own innovative biotech platform.

A Vancouver firm's revolutionary tech, backed by government funds, aims to decarbonize metal recovery and secure North America's platinum supply chain.